Sarantis S.A. (SAR)
LSE
Closed
Oct 7, 2026
Day's Range
27.0052 wk Range
9.00Overview - SAR - Sarantis S.A.
Key Statistics
Valuation
Enterprise Value
40.20M
P/E (Trailing)
‪-1,250.00‬
P/E (Forward)
‪-0.08‬
PEG Ratio
‪-0.08‬
Price / Book
‪3,280.56‬
EV / EBITDA
‪-11.88‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-60.70%‬
Return on Equity
‪-178.45%‬
Ownership
Shares Outstanding
138.06M
Float
132.72M
Held by Insiders
‪3.72%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-0.54‬
50-Day Avg
‪28.90‬
200-Day Avg
‪21.68‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - SAR - Sarantis S.A.
Peers - SAR - Sarantis S.A.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- SARLSESarantis S.A.4.19BMarket Cap+21.67%52-week change-1250.00P/E (Trailing)‪0.00%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - SAR - Sarantis S.A.
About
Sarantis S.A. is a prominent consumer goods company known for producing and distributing a diverse range of personal care, household, and healthcare products. Established in Greece, the company maintains a strong presence across Europe, particularly in the Balkans and Eastern Europe, where it caters to a wide array of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
